• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Molecular Partners AG - American Depositary Shares (NQ:MOLN)

4.090 +0.080 (+2.01%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Molecular Partners AG - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference
January 11, 2026
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics
December 11, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
December 07, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action
November 12, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
November 03, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
November 03, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
October 30, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Looking Into Molecular Partners's Recent Short Interest ↗
September 03, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 26, 2025
 
Via Benzinga
News headline image
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
August 26, 2025
 
Via Benzinga
News headline image
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket ↗
August 26, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 25, 2025
 
Via Benzinga
News headline image
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
August 25, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Earnings Scheduled For August 25, 2025 ↗
August 25, 2025
 
Via Benzinga
News headline image
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
August 21, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
July 25, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
July 22, 2025
 
Via Benzinga
News headline image
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
June 22, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
June 11, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
June 10, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners to Present at Upcoming Investor Conferences
May 19, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Reports Financial Results and Highlights from Q1 2025
May 15, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
April 25, 2025
 
Via Benzinga
News headline image
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
April 25, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
April 16, 2025
From Molecular Partners
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
April 08, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
April 07, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
March 28, 2025
 
Via Benzinga
News headline image
Molecular Partners to hold three poster presentations at AACR 2025
March 25, 2025
From Molecular Partners
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap